Dataset Information

Effect of MAOI on antitumor immunity in a B16-OVA melanoma tumor model

ABSTRACT: MAOIs, a class of antidepressant drugs that inhibit the degradation of monoamine neurotransmitters including serotonin, have been shown to significantly enhance antitumor immunity. Employig a single cell sequencing approch using 10xGemonics scRNAseq, we investigated how MAOI alters tumor-infiltrating CD8 T cell compartment and signaling pathways. This study provides new insights into the mechanistic differences in how MAOIs and SSRIs regulate CD8 T cell antitumor immunity.

ORGANISM(S): Mus musculus

PROVIDER: GSE286271 | GEO | 2025/05/27

REPOSITORIES: GEO

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:Selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine are the most common treatment for major depression. However, approximately 50% of depressed patients fail to achieve an effective treatment response. Understanding how gene expression systems relate to treatment responses may be critical for understanding antidepressant resistance. Transcriptome profiling allows for the simultaneous measurement of expression levels for thousands of genes and the opportunity to utilize this information to determine mechanisms underlying antidepressant treatment responses. However, the best way to relate this immense amount of information to treatment resistance remains unclear. We take a novel approach to this question by examining dentate gyrus transcriptomes from the perspective of a stereotyped fluoxetine-induced gene expression program. Expression programs usually represent stereotyped changes in expression levels that occur as cells transition phenotypes. Fluoxetine will shift transcriptomes so they lie somewhere between a baseline state and a full-response at the end of the program. The position along this fluoxetine-induced gene expression program (program status) was measured using principal components analysis (PCA). The same expression program was initiated in treatment-responsive and resistant mice but treatment response was associated with further progression along the fluoxetine-induced gene expression program. The study of treatment-related differences in gene expression program status represents a novel way to conceptualize differences in treatment responses at a transcriptome level. Understanding how antidepressant-induced gene expression program progression is modulated represents an important area for future research and could guide efforts to develop novel augmentation strategies for antidepressant treatment resistant individuals. 38 samples, 2 dentate regions (dorsal/ventral), 3 groups (control, antidepressant resistant (4 mice), antidepressant responsive (7 mice), untreated (8 mice).

Dataset Information

Effect of MAOI on antitumor immunity in a B16-OVA melanoma tumor model

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets